Wired for Discovery
Wired for DISCOVERY
Mark Bear ’75 is Applying Decades of Neuroscience Research to New Treatments for Brain and Vision Disorders
BY SARA C.P. WILLIAMS
[Top Portrait by David Sella]
Mark Bear ’75 has spent his career unlocking one of the brain’s most fascinating abilities: its power to change and adapt based on what it experiences. But long before he became a neuroscientist making groundbreaking discoveries, Mark’s own brain was shaped by his time at St. Stephen’s School. The curiosity, collaboration, and determination that drive his research today were already forming back then, sparked by inspiring teachers and challenging coursework.
“I learned how to learn at St. Stephen’s,” says Mark. “Then, the question was how does the brain learn?”
Today, Mark’s lab at the Massachusetts Institute of Technology (MIT) is testing new treatments for “lazy eye” and for Fragile X syndrome—a leading inherited cause of intellectual disability and autism. In both cases, he has developed drugs that work by precisely altering how the brain forms or weakens connections between brain cells.
“I’ve gotten a lot of joy over the years from tackling the challenge of understanding the brain at a fundamental level,” says Mark. “And it would really be the capstone of my career if we could advance these treatments into the clinic.”
The Spark of Discovery
Growing up, Mark was captivated by the brain. A Christmas list from his early childhood included a model of the human brain. When he was six, Mark watched the television coverage of John F. Kennedy’s assassination and listened to reporters speculate on the effects of a bullet to the brain.
“I remember sitting there being amazed, because I had never thought about what goes on inside the skull before that,” says Mark. “It initiated this lifelong interest in the brain.”
Throughout his years at St. Stephen’s, Mark continued to remain fascinated by science; he credits physics teacher and St. Stephen’s grad Marty Baumberger ’61 with showing him how even complex topics like the theory of relativity could be made simple.
As an undergraduate at Duke University, Mark joined a research lab where he experienced the thrill of scientific discovery for the first time. Mark, working with a postdoctoral fellow, carried out research to show how brain cells connected with each other. The experiments revealed a previously unknown cluster of brain cells involved in vision.
“All of us were whooping and hollering and giving high-fives. I just remember vividly at the time thinking, ‘I can’t believe we didn’t know this already and I can’t believe I, as an undergraduate, could make this discovery,’” he says. “That is what gave me the confidence to keep going in science.”
Rewiring Vision
In graduate school at Brown University, and then when he launched his own lab, Mark’s research revolved around the emerging field of synaptic plasticity—the idea that the brain’s connections are constantly strengthening or weakening based on experience.
“Synaptic plasticity is fundamental to neuroscience,” Mark explains. “Experiences during childhood, or during high school, or any other time, shape our brains.”
PATH AND IMPACT
EDUCATION
Ph.D. degree, Brown University, 1984
B.Sc. degree, Duke University, 1979
RESEARCH AREAS
• Vision and visual cortex
• The mechanisms of visual recognition memory
• Synaptic plasticity
• The pathophysiology and treatment of amblyopia
• The pathophysiology and treatment of fragile X syndrome
PUBLICATIONS
In addition to publishing more than 200 papers, Mark co-authored a textbook with Barry Connors and Michael A. Paradiso, “Neuroscience: Exploring the Brain.” The 5th Edition is coming out this summer.
SIGNIFICANT MEMBERSHIPS
Mark has more than 20 significant memberships, including the following very prestigious honors:
• Member, National Academy of Medicine, 2022–Present
• Elected Fellow, American Academy of Arts and Sciences, 2004
• Elected Fellow, American Association for the Advancement of Science, 2003
AWARDS
• 2023 Julius Axelrod Prize from the Society for Neuroscience
• 2021 Disney Award for Amblyopia Research, Research to Prevent Blindness
• 2018 Beckman-Argyros Vision Award
• 2015 IPSEN Foundation Neuroscience Prize
• 2012 Ray Fuller Award, American Society for Pharmacology and Experimental Therapeutics
• 2011 Award for Outstanding Contributions to the Study of Metabotropic Glutamate Receptors, 7th International mGluR Meeting, Taormina, Italy
• 2011 Pioneer Award, FRAXA Research Foundation
• 2006 William and Enid Rosen Award for Outstanding Contributions to Understanding Fragile X Syndrome, National Fragile X Foundation
• 2000 Brown University Elizabeth H. Leduc Award for Teaching Excellence
• Brown University Class of 2000 Barrett Hazeltine Citation for Teaching Excellence
• 1993 Fogarty Senior International Fellowship
• 1993 Society for Neuroscience Young Investigator Award
Mark’s studies began to show how, at a molecular level, brain cell connections called synapses became stronger or weaker. He pioneered the concept of metaplasticitiy—the idea that different conditions can change how easy it is for the brain to strengthen or weaken these synapses. His research revealed that previous activity in the brain can raise or lower the threshold for change, helping to explain why some experiences stick while others fade.
One of the main models that Mark used to study metaplasticity was the visual system in the brain. His early work showed how temporarily covering one eye in young animals caused long-lasting changes in brain wiring, altering how synapses strengthen and weaken. Over time, this research transformed the understanding and treatment of amblyopia, commonly known as “lazy eye.”
A condition that affects about 3% of the global population, amblyopia occurs when the brain favors one eye over the other. Traditionally, it was considered irreversible in adults—who struggle with blurry vision, poor depth perception and eye fatigue. But Mark challenged that belief.
Drawing on decades of research into synaptic plasticity, he and his team developed an approach that uses drugs to temporarily inactivate the signals from either the strong eye or both eyes to the brain. Mark explains that this “reboot” gives the brain a chance to rewire itself and respond to the weaker eye once again.
“It actually induces the brain to start making new connections,” he says. “It’s very profound and impactful.”
The strategy was successful in animal models and his lab is now moving it closer to clinical trials. If successful in humans, the treatment could offer new optimism to millions of people who were once told their vision could never improve.
Mark in the lab [Photo by Nina Palisano]
Tackling Fragile X
While that work focused on how the brain processes visual input, Mark’s next major project explored how these same brain mechanisms go awry in a rare but devastating genetic condition.
During their research on how the brain’s connections form and change, Mark’s lab discovered that the molecules that coaxed brain cells to make new connections were not functioning correctly in people with Fragile X syndrome. He proposed that overactive cellular responses to a brain molecule, called mGluR5, disrupted how brain circuits formed, contributing to the learning difficulties, sensory sensitivities, and behavioral challenges seen in Fragile X. What’s more, he hypothesized that blocking mGluR5 might reverse some of the damage.
It was a bold idea, and the science held up. Mark’s team was able to correct symptoms of Fragile X in mice by dialing down the activity of mGluR5. The findings sparked enormous interest across the scientific community – and hope amongst patients and their families.
“Throughout the course of my research on Fragile X, I’ve met a lot of families with children with Fragile X, and it’s a terrible disease,” says Mark. “My spine was tingling when we had results that suggested we could do something to help them.”
Early clinical trials of mGluR5 blockers in patients, however, suggested that although the drugs worked in the short term, they lost effectiveness over time due to the brain’s ability to adapt. The expectations for those trials were so high that their failure led to large amounts of negative publicity on Mark’s approach to treating Fragile X, garnering headlines in scientific journals citing disappointment, and “what went wrong.” In the wake of the results, pharmaceutical companies began to shy away from funding new research on mGluR5.
Mark, however, remained committed to the work—and to the idea that conceptually related treatment approaches could still work. Recently, he and his colleagues discovered a new molecular target that overcomes the problem of resistance with the earlier drugs, sustaining the effects on the brain for much longer. Results using the new compounds, in both mice and humans, are very encouraging.
Mark has founded his own startup, Allos Pharma, to try to raise money for clinical trials of the drugs. Many of the same molecular pathways important in Fragile X are also at play in autism spectrum disorders, and studies have shown the same drug improves social function in children with autism.
“We’ve corrected Fragile X in mice many times over,” he says. “I still believe we can do it in humans.”
Lessons that Last
Despite publishing more than 200 papers, receiving prestigious national awards like the Julius Axelrod Prize from the Society of Neuroscience, and being elected to the National Academy of Medicine, Mark says his greatest accomplishment is the mentorship he’s provided to students. He has taught introductory neuroscience to more than 10,000 students, written a leading neuroscience textbook for undergraduates, trained more than 25 Ph.D. candidates, and mentored countless postdoctoral fellows in his lab.
“My individual contribution to science pales in comparison with the contributions all these people are making,” says Mark.
He believes much of his success can be traced back to the habits and values he developed at St. Stephen’s. He credits the school not just with academic rigor—teaching him how to write and think critically—but also with helping him feel comfortable around adults, behave professionally, and engage meaningfully with ideas, even those as complex as Chaucer or the Bible. “It prepared me to be an adult,” he says. “And it gave me really great examples of how to teach effectively.”
He adds that faculty members never disparaged students for failing to understand something; always patiently explaining ideas in different ways. That open dialogue taught Mark how to work with scientists and clinicians from all walks of life, including long-time friend and Nobel Prize winning physicist Leon Cooper.
“His theories really influenced my work on the brain and I would say probably my work influenced his ideas,” says Mark. “Even though we were speaking different languages, we had a super fruitful collaboration.”
When asked what advice he would give to current St. Stephen’s and St. Agnes students, Mark returns to the idea that the school taught him how to learn. That, he says, gave him the ability to figure out what career path he wanted to pursue.
“Don’t differentiate too early, because you don’t know as an 18-year-old what new things you’ll be exposed to,” he says. “St. Stephen’s and St. Agnes teaches you how to learn and conduct yourself, and when you get to college you can then take full advantage of this new universe of opportunities to learn different things. Professors love to teach those who love to learn.”
Ultimately, Mark’s own research was shaped by the colleagues, students, patients, and ideas circulating around him, just as his early fascination with the brain was shaped by the experiences and mentors he encountered at St. Stephen’s. And that, in a way, is the ultimate lesson of his work: our experiences shape us—and our brains—in ways both seen and unseen, every single day.
THINGS I LEARNED AT ST. STEPHEN’S
To write well and tell an interesting story.
The first few lines of Chaucer’s “Canterbury Tales,” which I remember to this day and which so impressed my girlfriend that she married me!
To behave like an adult, as St. Stephen’s held us to a higher standard of behavior.
To feel comfortable in the company of adults and hold my own in conversations. This helped me become a college faculty member at the young age of 30.
I learned how to teach through the mentorship of St. Stephen’s teachers, which was so meaningful to me. You learn to teach by being taught by great teachers.
Although I am not religious, I learned the lessons of the Bible and they enriched me as a human being and were integral to preparing me for college and life and what it means to be an adult.